FDA pushing back safety compliance deadlines for agricultural water standards because they are “complicated” and “costly”

(Natural News) When it comes to granting its blessing for substances to be legally marketed as preventing or curing disease, the U.S. Food and Drug Administration (FDA) seems to have no problem extorting upwards of several million dollars per substance in “New Drug Application” (NDA) fees from companies who wish to buy the government’s permission…

View original article